Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting

NCT06766084 is registered in ClinicalTrials.gov with Technion, Israel Institute of Technology as lead sponsor.

NCT NCT06766084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06766084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting
Lead sponsor
Technion, Israel Institute of Technology
Phase
Observational
Overall status
Completed
Start date
January 1, 2009
Completion date
December 31, 2023
Enrollment
7,878 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cabg, revascularization